Huitt v. TEVA Pharmaceuticals USA, Inc.

CourtDistrict Court, E.D. California
DecidedSeptember 22, 2020
Docket2:20-cv-00954
StatusUnknown

This text of Huitt v. TEVA Pharmaceuticals USA, Inc. (Huitt v. TEVA Pharmaceuticals USA, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Huitt v. TEVA Pharmaceuticals USA, Inc., (E.D. Cal. 2020).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 EASTERN DISTRICT OF CALIFORNIA 10 ----oo0oo---- 11 12 PATRICIA HUITT, No. 2:20-cv-00954-WBS-KJN 13 Plaintiff, 14 v. MEMORANDUM AND ORDER RE: DEFENDANTS TEVA WOMEN’S 15 TEVA PHARMACEUTICALS USA, INC., HEALTH, LLC, TEVA WOMEN’s TEVA WOMEN’S HEALTH LLC; TEVA HEALTH, INC. AND TEVA 16 WOMEN’S HEALTH INC. et al., PHARMACEUTICAL USA, INC.’S MOTIONS TO DISMISS 17 Defendants. 18 19 ----oo0oo---- 20 Plaintiff Patricia Huitt (“plaintiff” or “Huitt”) 21 brought this action against Teva Women’s Health, LLC, Teva 22 Women’s Health, Inc., and Teva Pharmaceutical USA, Inc. 23 (“defendants” or “Teva”) seeking damages related to the 24 defendants’ design, manufacture, surveillance, sale, marketing, 25 advertising, promotion, labeling, packaging, and distribution of 26 the ParaGard Intrauterine Medical Device (“ParaGard IUD”). 27 Before the court are the Teva defendants’ substantively identical 28 motions to dismiss for failure to state a claim upon which relief 1 can be granted under Federal Rule of Civil Procedure 12(b)(6). 2 (“Mots. to Dismiss” (Docket Nos. 9, 12).) 3 I. Factual and Procedural Background 4 Plaintiff was implanted with a ParaGard IUD in 2016. 5 (See Compl. at ¶ 48) (Docket No. 1). In April 2018, plaintiff 6 went to have the ParaGard IUD removed in Sacramento, California. 7 (Id. at ¶ 50.) An ultrasound of plaintiff’s pelvis revealed that 8 the ParaGard IUD was mispositioned. (See id.) Plaintiff’s 9 healthcare provider attempted to remove the ParaGard IUD as 10 instructed by Teva. (Id. at ¶ 51.) However, only a portion of 11 the ParaGard IUD was retrieved, with one arm missing. (Id.) On 12 May 10, 2018, plaintiff’s physician removed the ParaGard IUD arm 13 via hysteroscope. (Id. at ¶ 52.) Plaintiff alleges that neither 14 she nor her doctors were provided with warnings from the 15 defendants of the risk of ParaGard IUD failure and injury or 16 adequate warning about the risks in removing the ParaGard IUD. 17 (Id. at ¶ 53.) As a result, plaintiff claims that she has 18 suffered significant bodily and mental injuries, pain and 19 suffering, loss of earnings and earning capacity, and has 20 incurred and will incur medical expenses. (Id. at ¶ 56.) 21 On May 11, 2020, plaintiff brought this action against 22 defendants alleging: (i) negligence, (ii) strict liability design 23 defect, (iii) strict liability manufacturing defect, (iv) strict 24 liability failure to warn, (v) common law fraud, (vi) negligent 25 misrepresentation, (vii) breach of express warranty, (viii) 26 breach of implied warranty, (ix) violation of consumer protection 27 laws, (x) gross negligence, and (xi) seeking punitive damages. 28 (See generally Compl.) 1 II. Legal Standard 2 Federal Rule 12(b)(6) allows a defendant to assert a 3 defense by motion for “failure to state a claim upon which relief 4 can be granted.” Fed. R. Civ. P. 12(b)(6). The inquiry before 5 the court is whether, accepting the allegations in the complaint 6 as true and drawing all reasonable inferences in the plaintiff’s 7 favor, the plaintiff has stated a claim to relief that is 8 plausible on its face. See Ashcroft v. Iqbal, 556 U.S. 662, 678 9 (2009). “The plausibility standard is not akin to a ‘probability 10 requirement,’ but it asks for more than a sheer possibility that 11 a defendant has acted unlawfully.” Id. at 678. “Threadbare 12 recitals of the elements of a cause of action, supported by mere 13 conclusory statements, do not suffice.” Id. Rather, “[w]hile 14 legal conclusions can provide the framework of a complaint, they 15 must be supported by factual allegations.” Id. at 679. 16 A statute of limitations defense “may be raised by a 17 motion for dismissal or by summary judgment motion.” Jablon v. 18 Dean Witter & Co., 614 F.2d 677, 682 (9th Cir. 1980). “If the 19 running of the statute is apparent on the face of the complaint, 20 the defense may be raised in a motion to dismiss.” Id. If 21 relief is barred by the applicable statute of limitations, “the 22 complaint is subject to dismissal for failure to state a claim . 23 . .” Jones v. Bock, 549 U.S. 199, 215 (2007). 24 III. Discussion 25 California law supplies the statute of limitations to 26 be applied in a diversity action on state law claims. See 27 Yenidunya Invs., Ltd. v. Magnum Seeds, Inc., No. 2:11-1787 WBS 28 CKD, 2011 WL 5241350, *3 (E.D. Cal. Oct. 3, 2011) (citing Walker 1 v. Armco Steel Corp., 446 U.S. 740, 752–53 (1980)). California 2 Code of Civil Procedure § 335.1 establishes a two-year statute of 3 limitations for an action for personal injury caused by the 4 alleged wrongful act or negligence of another. See Cal. Code 5 Civ. Proc. § 335.1. This limitations period on personal injury 6 claims based upon defective products applies to all causes of 7 action asserted in a personal injury action, regardless of the 8 legal theory invoked. Eidson v. Medtronic, Inc., 981 F. Supp. 2d 9 868, 893 (N.D. Cal. 2013) (citing Soliman v. Philip Morris Inc., 10 311 F.3d 966, 971 (9th Cir. 2002)). 11 Defendants initially contended that plaintiff’s cause 12 of action accrued “in April 2018, and certainly no later than May 13 10, 2018.” (See Teva Pharmaceutical USA’s Mot. to Dismiss at 14 14 (“Teva USA’s MTD”) (Docket No. 12).) Defendants argue that 15 because plaintiff did not file her complaint until May 11, 2020, 16 her claims are time-barred under California Code of Civil 17 Procedure § 335.1. (Id.) However, May 10, 2020, was a Sunday. 18 Pursuant to California Code of Civil Procedure § 12(a), “if the 19 last day for the performance of any act provided or required by 20 law to be performed within a special period of time is a holiday, 21 then that period is hereby extended to and including the next day 22 that is not a holiday.” See Cal. Code Civ. Proc. § 12(a). 23 California Code of Civil Procedure § 10 explains that “[h]olidays 24 within the meaning of the code are every Sunday and any other 25 days that are specified.” See Cal. Code Civ. Proc. § 10. 26 Therefore, if plaintiff’s cause of action accrued on May 10, 27 2018, when the embedded arm of her ParaGard IUD was removed, she 28 is not time-barred under the two-year statute of limitations. 1 Defendants now withdraw their argument that the claim 2 “certainly accrued no later than May 10, 2018,” (see Teva USA’s 3 MTD at 14), and instead emphasize that plaintiff’s claims accrued 4 in April 2018 and should be time-barred under the statute of 5 limitations based on that date. (See Reply in Supp. of Mot. to 6 Dismiss at 3 (“Reply”) (Docket No. 17).) Accordingly, in order 7 to determine whether plaintiff’s complaint is time-barred, the 8 court must analyze when plaintiff’s cause of action accrued. 9 A. Accrual 10 Generally speaking, “a cause of action accrues at ‘the 11 time when the cause of action is complete with all of its 12 elements.’” See Fox v. Ethicon Endo-Surgery, Inc., 35 Cal. 4th 13 797, 806 (2005) (citing Norgart v. Upjohn Co., 21 Cal. 4th 383, 14 397 (1999)). The elements of a cause of action are generically 15 referred to by sets of terms like wrongful conduct, causation, 16 and injury or harm. See Norgart, 21 Cal. 4th at 397.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Walker v. Armco Steel Corp.
446 U.S. 740 (Supreme Court, 1980)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Soliman v. Philip Morris Incorporated
311 F.3d 966 (Ninth Circuit, 2002)
Norgart v. Upjohn Co.
981 P.2d 79 (California Supreme Court, 1999)
Richards v. CH2M Hill, Inc.
29 P.3d 175 (California Supreme Court, 2001)
People v. Carson
104 P.3d 837 (California Supreme Court, 2005)
Hill v. Department of Defense
981 F. Supp. 2d 1 (District of Columbia, 2013)
Long v. Serrano
55 Cal. 20 (California Supreme Court, 1880)
Brown v. Crandall
198 Cal. App. 4th 1 (California Court of Appeal, 2011)
Lopez v. Smith
203 F.3d 1122 (Ninth Circuit, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
Huitt v. TEVA Pharmaceuticals USA, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/huitt-v-teva-pharmaceuticals-usa-inc-caed-2020.